p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab
Article in Scientific Reports (September 2023)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.
Article in Molecular Cancer Research (July 2023)
Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence
Article in Recent Patents on Anti-Cancer Drug Discovery (January 2023)